Anjana Devi Tangutur | Cancer Biology | Best Researcher Award

Dr. Anjana Devi Tangutur | Cancer Biology | Best Researcher Award

CSIR-Indian Institute of Chemical Technology- India

Author Profile

Early Academic Pursuits

Dr. Anjana Devi Tangutur embarked on her academic journey with a strong foundation in the life sciences. She completed her undergraduate degree in Microbiology, Botany, and Chemistry from St. Pious X Degree College, Osmania University, Hyderabad in 1998. This was followed by a Master’s degree in Microbiology from the Department of Microbiology, Osmania University in 2000, where she was a university ranker. She then pursued a Ph.D. in Biological Sciences (Cell and Molecular Biology) at the Centre for Cellular and Molecular Biology (CCMB), Hyderabad, completing her doctorate in 2009.

Professional Endeavors

Dr. Tangutur’s professional career has been marked by a progressive ascent through various scientific roles at the CSIR-Indian Institute of Chemical Technology (CSIR-IICT) in Hyderabad. She started as a Junior Scientist in 2008, advancing to Scientist in 2011, Senior Scientist in 2016, and finally Principal Scientist in 2020. In addition to her role at CSIR-IICT, she also serves as an Honorary Associate Professor at AcSIR.

Contributions and Research Focus

Dr. Tangutur’s research primarily focuses on applied biology, with significant contributions in the fields of molecular and cellular biology, proteomics, and cancer research. She has published 40 research papers and three book chapters, reflecting her prolific contribution to the scientific community. Her research includes the identification of early diagnostic biomarkers and the development of novel therapeutic compounds. She has also supervised six Ph.D. scholars, with three currently working as postdoctoral fellows in reputed international laboratories, and overseen numerous M.Sc. and M.Pharmacy dissertations.

Accolades and Recognition

Throughout her career, Dr. Tangutur has received numerous awards and recognitions, underscoring her excellence in research and academia. Some notable awards include:

  • University ranker in M.Sc. Microbiology from Osmania University (2000)
  • Sixth ranker in the Osmania University M.Sc. entrance test for Genetics, Microbiology, and Environmental Sciences (1998)
  • Junior and Senior Research Fellowship from CSIR, India (2001-2005)
  • Fellow of the Society for Applied Biotechnology (FSAB) in 2012
  • Award for Research Excellence at the INDO-GLOBAL Education Summit in 2013
  • Biotechnology Career Advancement and Reorientation (BioCARe) award for women scientists from DBT, India (2013-2016)
  • Best Oral Presentation Award at the “Biotechnology for Better Tomorrow” conference in Florida, USA (2015)
  • Best Paper Award at the “Recent Trends in Microbial Biotechnology” International Conference (2015)

Impact and Influence

Dr. Tangutur’s work has had a significant impact on the field of chemical biology and biotechnology. Her research on diagnostic biomarkers and therapeutic compounds has potential applications in cancer treatment and viral infection management. As a life member of several prestigious scientific organizations such as the Proteomic Society of India, Indian Science Congress Association, Indian Association of Cancer Research, and the National Environmental Science Academy, she actively contributes to the scientific community and collaborates with other researchers to advance scientific knowledge.

Legacy and Future Contributions

Dr. Tangutur continues to contribute to scientific research and education through her ongoing projects and mentorship of young scientists. Her current projects, including those funded by CSIR and DBT, aim to explore new frontiers in chemical biology and proteomics. Her legacy is marked by her commitment to scientific excellence and her role in shaping the careers of emerging researchers. As she continues her work, Dr. Tangutur is poised to make further significant contributions to science and medicine, particularly in the development of novel diagnostic and therapeutic strategies.

Megala Jayaraman | Targeted Drug Delivery for Gastrointestinal Cancer | Best Researcher Award

Dr. Megala Jayaraman - Targeted Drug Delivery for Gastrointestinal Cancer - Best Researcher Award 🏆 

SRM Institute of Science and Technology - India

Professional Profiles

Early Academic Pursuits

Her academic journey commenced with a strong foundation in life sciences, culminating in a Ph.D. in Cancer Biology & Immunogenetics from Bharathiar University. Her early academic pursuits included an M.Phil. in Biochemistry from Annamalai University, and she further expanded her knowledge with postgraduate studies in bioinformatics and biochemistry. This diverse educational background equipped her with the necessary skills to embark on a fulfilling career in research and academia.

Professional Endeavors

As an Associate Professor in the Department of Genetic Engineering at SRM Institute of Science and Technology, she has dedicated herself to advancing knowledge in cancer biology and immunogenetics. With nearly two decades of experience in academia, she has held various teaching and research positions at esteemed institutions, including Ethiraj College for Women and Vels University. Her expertise in life sciences and her passion for research have driven her professional endeavors towards understanding and combating gastrointestinal cancer.

Contributions and Research Focus in Targeted Drug Delivery for Gastrointestinal Cancer

Her research focus lies in gastrointestinal cancer treatment, with a particular emphasis on targeted drug delivery systems. Through her innovative research endeavors, she aims to develop novel drug delivery strategies to enhance the efficacy of cancer therapy while minimizing adverse effects. Her contributions in oncology, chemotherapy, and drug delivery systems have the potential to revolutionize gastrointestinal cancer treatment and improve patient outcomes.

Accolades and Recognition

Her exceptional contributions to cancer research have garnered recognition within the scientific community. Her research excellence has been acknowledged through awards, including the Best Researcher Award in Targeted Drug Delivery for Gastrointestinal Cancer. Her dedication to advancing cancer therapy through innovative drug delivery systems has earned her accolades and appreciation from peers and colleagues.

Impact and Influence

Her research has made a significant impact on the field of oncology and cancer therapy. Her work in targeted drug delivery for gastrointestinal cancer holds promise for improving treatment outcomes and enhancing patient care. Through her contributions to academia and research, she has influenced the direction of cancer research and inspired future generations of scientists to explore innovative approaches to cancer treatment.

Legacy and Future Contributions

Her legacy lies in her pioneering contributions to targeted drug delivery for gastrointestinal cancer. Her research endeavors have the potential to transform the landscape of cancer therapy, offering new hope to patients battling gastrointestinal tumors. As she continues her academic and research pursuits, her work will undoubtedly leave a lasting impact on oncology, drug delivery systems, and the broader field of cancer research. Her future contributions will further advance our understanding of gastrointestinal cancer treatment, paving the way for improved therapies and better patient outcomes.

Citations

  • Citations               234
  • h-index                  8
  • i10-index               6

Notable Publications